Kicking-off 2024 &
Breaking Through
The Health Minister of India recently heralded iBreastExam as "A New Model for Breast Cancer Screening". Following real and impactful implementations, global recognitions, and awards, our proud partners and healthcare leaders are scaling iBreastExam and cervAIcal to serve hundreds of thousands, across Latin America, Southeast Asia and India.
We're also announcing RaKSA - world's first, triple cancer assessment (breast, cervical and oral) in a single visit.
This is innovative, inclusive & equitable women's health, breaking through!
Q1 2024
Impact with Innovation. At scale.
iBreastExam partners up with a massive health brigade in the state of Chihuahua - offering to reshape the breast health landscape for Mexico while empowering women equitably.
A Systematic Review in leading journal, JCO Global Oncology
Excerpt from Conclusion "Our findings underscore the potential clinical utility and applicability of iBE as a prescreening and triaging tool, which may aid in reducing the burden of patients undergoing diagnostic imaging in lower- and middle-income countries."
Exciting & Upcoming!
OrCA, just days away!
Our new innovation for the early detection of oral cancer is just days away from its official release.
RaKSA: Triple Cancer Screening. For All.
We're reshaping and reimagining the world of women's cancers and their early detection. Our novel approach will soon bring breast, cervical and oral cancer screening to women around the world. RaKSA will be, by far the most affordable, clinically effective and truly feasible mechanism to fight common cancers that currently wreaking havoc in the developing world.
Past Newsletters
Building a trail of global impact and partnerships
UE LifeSciences Inc. Copyright © 2024 | Terms & Conditions | Privacy Policy